Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global EClinical Solutions Market to reach USD 23.15 billion by the end of 2030.

Global EClinical Solutions Market Size Study & Forecast, by Product (EDC and CDMS, CTMS), Clinical Analytics Platforms, RTSM, Clinical Data Integration Platforms, eCOA, Safety Solutions, eTMF), by Delivery Mode (Web and Cloud based, On- Premise), by Development Phases, by End-use (Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers), and Regional Analysis, 2023-2030

Product Code: HLSHIT-78118011
Publish Date: 10-01-2024
Page: 200

Global EClinical Solutions Market is valued at approximately USD 8.06 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.1% over the forecast period 2023-2030. EClinical Solutions encompass a range of technology-driven tools, including electronic data capture and clinical data management systems, clinical trial management systems, and randomization and trial supply management. These solutions play a crucial role in the streamlined and enhanced management of clinical trial data. They provide a comprehensive set of tools for planning, overseeing, and monitoring clinical study portfolios by effectively organizing and integrating data generated during clinical trials. These solutions contribute to achieving favorable clinical research outcomes and ensuring compliance in submissions through the integration of contact management, calendars, monitoring, and document management. They facilitate efficient data entry, storage, and regulation, while also ensuring the authentication of data integrity and reliability. The implementation of eClinical Solutions contributes to expediting drug development timelines and enhancing the overall patient experience in the clinical research process. The rising externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies, the growing advantages of eClinical solutions, coupled with the presence of a strong range of products in the pipeline are the key driving factors for market growth across the globe.

In addition, the growing incorporation of software solutions in clinical trials is the most prominent factor that is propelling the market demand over the estimated period. The globalization of clinical trials, involving multiple sites and geographies, requires centralized and standardized data management systems. According to Statista, in 2019, there were approximately 325,776 clinical studies were registered worldwide, which is continuously rising and reaching 409,300 as of March 2022. eClinical Solutions enables seamless collaboration and data sharing across different locations, which is fueling the market demand globally. Moreover, the growing outsourcing of clinical trial processes to CROs, as well as the gradual shift from manual data interpretation to real-time data analysis presents various lucrative opportunities over the forecast years. However, the scarcity of skilled research professionals and lack of recognition are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global EClinical Solutions Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing target population and an increase in the prevalence of lifestyle-related conditions such as diabetes and cardiac disorders. The market is further propelled by the introduction of new products from eClinical solution providers and rising government grants within the region. Additionally, the presence of major industry players and access to advanced infrastructure are anticipated to contribute significantly to the regional market’s expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Substantial unmet medical needs and a rising incidence of chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are significantly propelling the market demand across the region. A growing trend involves outsourcing a considerable number of clinical trials to countries such as China, India, Korea, and Japan, given their substantial patient populations and cost advantages. This outsourcing practice has significantly fueled the adoption of eClinical solutions in these regions. The APAC market’s growth is further propelled by its status as an emerging economy, with government funding directed toward research and drug discovery, expected to bolster its expansion in the foreseeable future.

Major market players included in this report are:
Datatrak International, Inc.
Parexel International Corporation
Dassault Systemes
CRF Health
ERT Clinical
IBM Watson Health
Anju Life Sciences Software

Recent Developments in the Market:
Ø In June 2023, Syneos Health entered a collaboration with uMotif Limited, leveraging an advanced digital platform that integrates powerful Electronic Clinical Outcome Assessment (eCOA) and Electronic Patient-reported Outcomes (ePRO) capabilities. The objective of this partnership is to expedite clinical trials, enhancing the efficiency of delivering innovative medications to patients.
Ø In May 2023, eClinical Solutions LLC. unveils the development of its Artificial Intelligence (AI) and Machine Learning (ML) capabilities within the Elluminate IQ offering. This advancement enables data management teams to conduct data reviews with increased efficiency and scalability, offering ML and AI features.

Global EClinical Solutions Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Delivery Mode, Development Phases, End-use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Clinical Analytics Platforms
Randomization and Trial Supply Management (RTSM)
Clinical Data Integration Platforms
Electronic Clinical Outcome Assessment (eCOA)
Safety Solutions
Electronic Trial Master File (eTMF)

By Delivery Mode:
Web and Cloud based
On- Premise

By Development Phases:
Phase I
Phase II
Phase III
Phase IV

By End-use:
Hospitals/Healthcare providers
Academic Institutes
Pharma & Biotech Organizations
Medical Device Manufacturers

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. EClinical Solutions Market, by Region, 2020-2030 (USD Billion)
1.2.2. EClinical Solutions Market, by Product, 2020-2030 (USD Billion)
1.2.3. EClinical Solutions Market, by Delivery Mode, 2020-2030 (USD Billion)
1.2.4. EClinical Solutions Market, by Development Phases, 2020-2030 (USD Billion)
1.2.5. EClinical Solutions Market, by End-use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global EClinical Solutions Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global EClinical Solutions Market Dynamics
3.1. EClinical Solutions Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing presence of strong range of products Rising incorporation of software solutions in clinical trials
3.1.2. Market Challenges Scarcity of skilled research professionals Lack of recognition
3.1.3. Market Opportunities Growing outsourcing of clinical trial processes to CROs Gradual shift from manual data interpretation to real-time data analysis
Chapter 4. Global EClinical Solutions Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global EClinical Solutions Market, by Product
5.1. Market Snapshot
5.2. Global EClinical Solutions Market by Product, Performance – Potential Analysis
5.3. Global EClinical Solutions Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. EClinical Solutions Market, Sub Segment Analysis
5.4.1. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
5.4.2. Clinical Trial Management Systems (CTMS)
5.4.3. Clinical Analytics Platforms
5.4.4. Randomization and Trial Supply Management (RTSM)
5.4.5. Clinical Data Integration Platforms
5.4.6. Electronic Clinical Outcome Assessment (eCOA)
5.4.7. Safety Solutions
5.4.8. Electronic Trial Master File (eTMF)
Chapter 6. Global EClinical Solutions Market, by Delivery Mode
6.1. Market Snapshot
6.2. Global EClinical Solutions Market by Delivery Mode, Performance – Potential Analysis
6.3. Global EClinical Solutions Market Estimates & Forecasts by Delivery Mode 2020-2030 (USD Billion)
6.4. EClinical Solutions Market, Sub Segment Analysis
6.4.1. Web and Cloud based
6.4.2. On- Premise
Chapter 7. Global EClinical Solutions Market, by Development Phases
7.1. Market Snapshot
7.2. Global EClinical Solutions Market by Development Phases, Performance – Potential Analysis
7.3. Global EClinical Solutions Market Estimates & Forecasts by Development Phases 2020-2030 (USD Billion)
7.4. EClinical Solutions Market, Sub Segment Analysis
7.4.1. Phase I
7.4.2. Phase II
7.4.3. Phase III
7.4.4. Phase IV
Chapter 8. EClinical Solutions Market, by End-use
8.1. Market Snapshot
8.2. Global EClinical Solutions Market by End-use, Performance – Potential Analysis
8.3. Global EClinical Solutions Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
8.4. EClinical Solutions Market, Sub Segment Analysis
8.4.1. Hospitals/Healthcare providers
8.4.2. CROs
8.4.3. Academic Institutes
8.4.4. Pharma & Biotech Organizations
8.4.5. Medical Device Manufacturers
Chapter 9. Global EClinical Solutions Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. EClinical Solutions Market, Regional Market Snapshot
9.4. North America EClinical Solutions Market
9.4.1. U.S. EClinical Solutions Market Product breakdown estimates & forecasts, 2020-2030 Delivery Mode breakdown estimates & forecasts, 2020-2030 Development Phases breakdown estimates & forecasts, 2020-2030 End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada EClinical Solutions Market
9.5. Europe EClinical Solutions Market Snapshot
9.5.1. U.K. EClinical Solutions Market
9.5.2. Germany EClinical Solutions Market
9.5.3. France EClinical Solutions Market
9.5.4. Spain EClinical Solutions Market
9.5.5. Italy EClinical Solutions Market
9.5.6. Rest of Europe EClinical Solutions Market
9.6. Asia-Pacific EClinical Solutions Market Snapshot
9.6.1. China EClinical Solutions Market
9.6.2. India EClinical Solutions Market
9.6.3. Japan EClinical Solutions Market
9.6.4. Australia EClinical Solutions Market
9.6.5. South Korea EClinical Solutions Market
9.6.6. Rest of Asia Pacific EClinical Solutions Market
9.7. Latin America EClinical Solutions Market Snapshot
9.7.1. Brazil EClinical Solutions Market
9.7.2. Mexico EClinical Solutions Market
9.8. Middle East & Africa EClinical Solutions Market
9.8.1. Saudi Arabia EClinical Solutions Market
9.8.2. South Africa EClinical Solutions Market
9.8.3. Rest of Middle East & Africa EClinical Solutions Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Datatrak International, Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.3.2. OracleCorporation
10.3.3. Parexel International Corporation
10.3.4. Dassault Systemes
10.3.5. Bioclinica
10.3.6. CRF Health
10.3.7. ERT Clinical
10.3.8. eClinicalWorks
10.3.9. IBM Watson Health
10.3.10. Anju Life Sciences Software
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now